These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3188815)
21. Drugs and the liver. Symposium proceedings. 21-24 April 1998. Br J Clin Pharmacol; 1998 Oct; 46(4):351-9. PubMed ID: 9803983 [No Abstract] [Full Text] [Related]
22. Impaired elimination of meperidine in patients with liver disease. McHorse TS; Klotz U; Wilkinson G; Schenker S Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737 [No Abstract] [Full Text] [Related]
23. An introduction to clinical pharmacokinetics. Pfeifer HJ; Greenblatt DJ Compr Ther; 1979 Mar; 5(3):33-7. PubMed ID: 445982 [No Abstract] [Full Text] [Related]
24. Therapeutic drug monitoring. Pharmacokinetics. Taylor WJ Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671 [No Abstract] [Full Text] [Related]
25. The pharmacokinetics of meropenem. Drusano GL; Hutchison M Scand J Infect Dis Suppl; 1995; 96():11-6. PubMed ID: 7652497 [TBL] [Abstract][Full Text] [Related]
26. Investigation of biotransformation capacity in patients with chronic liver diseases by pharmacokinetic methods: experimental trials. Horváth T; Past T; Tatai Z; Pár A; Kádas I; Tapsonyi Z; Jávor T Pol J Pharmacol Pharm; 1984; 36(4):361-71. PubMed ID: 6396596 [TBL] [Abstract][Full Text] [Related]
27. [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites]. Wagner T; Heydrich D; Bartels H; Hohorst HJ Arzneimittelforschung; 1980; 30(9):1588-92. PubMed ID: 7193030 [TBL] [Abstract][Full Text] [Related]
30. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Gaillot J; Le Roux Y; Houghton GW; Dreyfus JF Sleep; 1987; 10 Suppl 1():7-21. PubMed ID: 3438645 [TBL] [Abstract][Full Text] [Related]
31. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]. Rameis H Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031 [TBL] [Abstract][Full Text] [Related]
32. [Side effects of drugs--predictable hazards for patients with liver disease]. Baumgarten R Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279 [No Abstract] [Full Text] [Related]
33. Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment. Peng JZ; Pulido F; Causemaker SJ; Li J; Lorenzo A; Cepeda C; García Cabanillas JA; DaSilva B; Brun SC; Arribas J J Clin Pharmacol; 2006 Mar; 46(3):265-74. PubMed ID: 16490802 [TBL] [Abstract][Full Text] [Related]
34. Vancomycin half-life in a patient with hepatic and renal dysfunction. Pachorek RE; Wood F Clin Pharm; 1991 Apr; 10(4):297-300. PubMed ID: 2032447 [No Abstract] [Full Text] [Related]
35. [Clinical pharmacokinetics and drug therapy in pediatrics]. Prandota J; Panków-Prandota L Pediatr Pol; 1979 Jul; 54(7):773-80. PubMed ID: 394111 [No Abstract] [Full Text] [Related]
36. [Drug metabolism in patients with liver disease (author's transl)]. Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410 [TBL] [Abstract][Full Text] [Related]
37. Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment. Gupta SK; Kantesaria B; Wang Z J Clin Pharmacol; 2007 Oct; 47(10):1283-91. PubMed ID: 17906161 [TBL] [Abstract][Full Text] [Related]
38. Pharmacology of pentamethylmelamine in humans. Benvenuto JA; Stewart DJ; Benjamin RS; Loo TL Cancer Res; 1981 Feb; 41(2):566-9. PubMed ID: 6778609 [TBL] [Abstract][Full Text] [Related]
39. [Determination of hepatic metabolic capacity: antipyrine pharmacokinetics in circulatory liver damage due to cardiac insufficiency]. Kettner W; Banditt P; Walther H Dtsch Z Verdau Stoffwechselkr; 1983; 43(6):255-66. PubMed ID: 6662064 [TBL] [Abstract][Full Text] [Related]